Overview

Chronic Clinical Effect of Acetazolamide

Status:
Completed
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The study seeks primarily to determine the chronic clinical effect of AZA on exercise capacity (6MWD) compared to placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Zurich
Treatments:
Acetazolamide